Patent · US Active

Bupropion hydrobromide polymorphs

US8349900B2 · kind B2 · utility

1Cited by

9References

7Claims

0Family size

Assignee

Valeant International Bermuda · BM

Inventors

Stefano Turchetta · Roma, IT
Maurizio Zenoni · Paullo, IT

Key dates

Filing date	Aug 6, 2009
Grant date	Jan 8, 2013
Priority date	—
Expiry date	Jan 13, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polymorphous and amorphous forms of bupropion hydrobromide are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.